Recon: HTA regulation: PICO consolidation goes well; US commission seeks research infrastructure revamp

• US negotiated Medicare prices for 15 more drugs to test cost savings promise (Reuters)
• US FDA approves Novartis' gene therapy for rare muscle disorder (Reuters)
• FDA's Pazdur questions legality of voucher program, sources say, in latest internal disagreement (Endpoints)
• Lawmakers probe FDA's new priority voucher program, cite corruption and rushed review concerns (Fierce Pharma)
• Walgreens nasal spray recalled over possible bacteria (The Hill)

• China Biotech Deals Grow as Country Turns From Copycat to Innovator (Bloomberg)
• Straumann reaffirms growth targets as it braces for China dental market shift (Reuters)
• England Becomes First In Europe To Reimburse Autolus’ CAR-T Aucatzyl (Pink Sheet)
• UK Off-Patent Industry Urges Focus On Five Priorities Ahead Of Govt Budget (Pink Sheet)
• EU HTA Regulation: PICO Consolidation Going Well, Analysis Feasibility A Challenge (Pink Sheet)
• Angelini faces UK marketing watchdog's wrath after speaker blasts 'stupid' EMA (Fierce Pharma)

• Novo Nordisk Drug Helps Patients Lose Weight, Lower Blood Sugar in Trial (Wall Street Journal)
• Where GLP-1s Weight-Loss Drugs Fall Short for Women (Bloomberg)
• JD Weighs at Least $1 Billion Bond Sale Linked to Health Unit (Bloomberg)
• Novartis plans to cut up to 550 jobs at Swiss facility (Reuters)
• Novartis was the sole bidder in $12B deal to buy Avidity (Endpoints)
• After 5 Years, Acid-Reducer Is Back on the Market (MedPage Today)

• Ceribell wins FDA clearance for seizure-detection algorithm in neonates (MedTech Dive)
• Okami raises $45M to commercialize vascular embolization devices (MedTech Dive)
• LDTs Aimed At Catching Cancers Early Hold Promise In Reducing Late-Stage Diagnoses, Study Shows (MedTech Insight)
• Medtech Sees Bigger Deals As Early Funding Tightens; LSI Is ‘Cautiously Optimistic’ For 2026 (MedTech Insight)

• GLP-1 users to make up 35% of food and beverage sales by 2030: report (Food Dive)
• More than 100 babies have received treatment for botulism in relation to ByHeart formula outbreak (Food Safety News)

• Federal biotech commission calls for retooling of scientific research infrastructure (STAT)
• Humana to Appeal Ruling Upholding Medicare Star Bonus Cuts (Bloomberg)
• UK-US drug pricing deal could come as early as this week, sources say (Endpoints)
• Pharma pros skeptical of letting AI loose on regulatory compliance submissions: survey (Fierce Pharma)
• SK Life Science Xcopri ad meets a roadblock with FDA untitled letter (Fierce Pharma)